1. Home
  2. NICE Guidance
  3. NICE Advice
  4. Evidence summaries

Systemic juvenile idiopathic arthritis: canakinumab

Evidence summary [ESNM36] Published: 18 March 2014

Advice

This evidence summary has been withdrawn. An NHS England clinical commissioning policy statement on biologic therapies for the treatment of juvenile idiopathic arthritis is available.